Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.01. | AFT Pharmaceuticals - Another R&D asset in the bag | 344 | Edison Investment Research | AFT Pharmaceuticals has announced the addition of another candidate, HY-091, to its R&D pipeline, for the management of vulvar lichen sclerosus (VLS), a skin condition with no curative treatments available.... ► Artikel lesen | |
22.01. | Accsys Technologies - Updating estimates for guidance and capital raise | 497 | Edison Investment Research | In September 2023, Accsys warned of weaker market conditions in the building materials and construction markets and in November, it stated not to expect trading conditions to improve materially until... ► Artikel lesen | |
22.01. | OSE Immunotherapeutics - Active year ahead for proprietary programmes | 392 | Edison Investment Research | OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf, neoepitope-based cancer vaccine) in second-line non-small... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.682 |
NEL | 1.667 |
SUPER MICRO COMPUTER | 1.656 |
NVIDIA | 1.650 |
TUI | 1.484 |
BAYER | 1.336 |
RHEINMETALL | 1.000 |
RENK GROUP | 930 |
PROSIEBENSAT.1 | 912 |
VOLKSWAGEN | 735 |
AMAZON | 699 |
PALANTIR TECHNOLOGIES | 698 |
TESLA | 687 |
MICROSTRATEGY | 636 |
DEUTSCHE BANK | 585 |
PLUG POWER | 571 |
BASF | 565 |
BYD | 557 |
THYSSENKRUPP | 542 |
COMMERZBANK | 535 |
AIXTRON SE | 532 |
SAP | 507 |
MERCEDES-BENZ | 506 |
ALLIANZ | 493 |
DEUTSCHE TELEKOM | 473 |